Eli Lilly to delay new studies due to coronavirus outbreak

[March 23, 2020]  (Reuters) - U.S. drugmaker Eli Lilly & Co said on Monday it would delay starting new studies and pause enrollment in most ongoing studies due to the coronavirus outbreak.

The company said it would continue trials where patients are already enrolled. The company added that it does not anticipate any change to its full-year forecast as a result of the coronavirus outbreak. [nPn3Vd82ja]

(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

[© 2020 Thomson Reuters. All rights reserved.]

Copyright 2020 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.